Gwendal Le Masson

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Activity-Dependent Regulation of Conductances in Model Neurons

Gwendal Le Masson, Eve Marder, L. F. Abbott · Science · 1993 · 343 citations

Natural Sciences, Biophysics, Neuroscience +17

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Ivo N. van Schaik, Vera Bril, Nan van Geloven et al. · The Lancet Neurology · 2017 · 269 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +11

Feedback inhibition controls spike transfer in hybrid thalamic circuits

Gwendal Le Masson, Sylvie Renaud, Damien Debay et al. · Nature · 2002 · 206 citations

Life Sciences, Neurobiology, Neuroscience +14

Synaptic background activity controls spike transfer from thalamus to cortex

Jakob Wolfart, Damien Debay, Gwendal Le Masson et al. · Nature Neuroscience · 2005 · 201 citations

Life Sciences, Neurobiology, Neuroscience +14